Article Details

Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in ... - B3C newswire

Retrieved on: 2022-12-15 12:09:29

Tags for this article:

Click the tags to see associated articles and topics

Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in ... - B3C newswire. View article details on HISWAI: https://www.b3cnewswire.com/202212152425/calypso-biotech-announces-first-patient-with-eosinophilic-esophagitis-dosed-in-anti-interleukin-15-il-15-monoclonal-antibody-caly-002-phase-1a-b-trial-and-animal-proof-of-concept-data-in-atopic-dermatitis.html

Excerpt

... and highly differentiated - monoclonal antibody neutralizing IL-15. ... Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody ...

Article found on: www.b3cnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up